[
  {"abstract_id": "ATTD-2026-O-101", "conference": "ATTD 2026", "session_date": "2026-02-21", "session_type": "Oral", "title": "Real-world outcomes of MiniMed 780G with aggressive 100 mg/dL target in adolescents", "presenter": "Battelino T, et al.", "topic": ["AID", "pediatric T1D"], "key_finding": "TIR 78.4%, GMI 6.7%, no severe hypos over 6 mo", "kor_relevance_score_note": "한국 소아 T1D AID 보험 등재 근거 보강", "relevance": ["AID"]},
  {"abstract_id": "ATTD-2026-P-247", "conference": "ATTD 2026", "session_date": "2026-02-22", "session_type": "Poster", "title": "Dexcom G7 vs FreeStyle Libre 4 head-to-head accuracy in Korean adults with T2D", "presenter": "박상준 외 (Park SJ et al., 순천향대 부천병원)", "topic": ["CGM", "Korean T2D"], "key_finding": "MARD G7 8.1%, Libre 4 8.4%, both meet ISO 15197 stricter criteria", "kor_relevance_score_note": "한국인 데이터, 닥터앤서 3.0 컨소시엄 산하", "relevance": ["CGM"]},
  {"abstract_id": "DTM-2026-S-44", "conference": "DTM 2026 (Diabetes Technology Meeting)", "session_date": "2026-11-06", "session_type": "Symposium", "title": "FDA PCCP guidance impact on AI-enabled DR screening: real-world post-market changes", "presenter": "Abramoff M, et al.", "topic": ["SaMD", "AI/ML", "PCCP"], "key_finding": "Two PCCP-authorized modifications, no new safety signals over 18 mo", "kor_relevance_score_note": "KFDA AI 변경관리 가이드라인 도입 근거", "relevance": ["SaMD"]},
  {"abstract_id": "ADA-2026-O-78", "conference": "ADA 2026", "session_date": "2026-06-20", "session_type": "Oral", "title": "iLet Bionic Pancreas pediatric pivotal results (ages 6-17)", "presenter": "Russell SJ, et al.", "topic": ["AID", "pediatric"], "key_finding": "HbA1c -0.5%, TIR +12.7% vs SAP at 13 wk", "kor_relevance_score_note": "FDA De Novo 소아 확대 근거 + KFDA·HIRA 평가 자료", "relevance": ["AID"]},
  {"abstract_id": "ADA-2026-P-512", "conference": "ADA 2026", "session_date": "2026-06-21", "session_type": "Poster", "title": "AspyreRx prescription DTx 90-day real-world HbA1c outcomes in commercial T2D population", "presenter": "Hsu W, et al.", "topic": ["DTx", "T2D"], "key_finding": "HbA1c -0.41% mean, NNT 6, sustained at 6 mo", "kor_relevance_score_note": "K-DTx 보험 평가 reference", "relevance": ["DTx"]},
  {"abstract_id": "EASD-2026-O-22", "conference": "EASD 2026", "session_date": "2026-09-17", "session_type": "Oral", "title": "AI-based retinal CVD risk in T2D: 5-year prospective validation (Reti-CVD/Dr. Noon)", "presenter": "Rim TH, et al. (메디웨일)", "topic": ["SaMD", "CV risk"], "key_finding": "HR 1.41 per SD, NRI 0.18 vs Framingham", "kor_relevance_score_note": "한국발 SaMD 글로벌 학회 핵심 발표, EU/KFDA 동시 적용", "relevance": ["SaMD"]},
  {"abstract_id": "EASD-2026-P-318", "conference": "EASD 2026", "session_date": "2026-09-18", "session_type": "Poster", "title": "DiGA-listed DTx for T2D: pooled effectiveness from German real-world claims (n=14,200)", "presenter": "Reichelt L, et al.", "topic": ["DTx", "RWE"], "key_finding": "HbA1c -0.38%, BMI -1.1, healthcare cost neutral at 12 mo", "kor_relevance_score_note": "K-DTx 보험 모델 정책 참고", "relevance": ["DTx"]},
  {"abstract_id": "KDA-2026-O-15", "conference": "KDA 2026 (대한당뇨병학회 추계학술대회)", "session_date": "2026-10-23", "session_type": "Oral (Korean)", "title": "한국형 AID 시스템 도입 1년 시점 효과 분석: MiniMed 780G 소아 T1D 코호트", "presenter": "김현민 외 (서울아산병원, 닥터앤서 3.0 컨소시엄)", "topic": ["AID", "Korean cohort"], "key_finding": "TIR 72.1% (입력 56.4%), HbA1c -0.7%, 중증 저혈당 0건/100인년", "kor_relevance_score_note": "한국 RWE, HIRA 급여 확대 핵심 근거", "relevance": ["AID"]},
  {"abstract_id": "KDA-2026-P-088", "conference": "KDA 2026", "session_date": "2026-10-24", "session_type": "Poster (Korean)", "title": "WELT-DM 디지털치료기기 12주 RCT 결과: HbA1c 및 식이지표 개선", "presenter": "이우찬 외 (웰트/삼성서울병원)", "topic": ["DTx", "Korean T2D"], "key_finding": "HbA1c -0.62% vs SoC -0.21%, p<0.001 (n=420)", "kor_relevance_score_note": "K-DTx 본허가 + NECA 평가 직접 근거", "relevance": ["DTx"]},
  {"abstract_id": "KSAD-2026-O-09", "conference": "KSAD 2026 (대한내분비학회 춘계)", "session_date": "2026-04-19", "session_type": "Oral (Korean)", "title": "한국 성인 T2D MDI 환자에서 CGM 보험 확대 6개월 RWE: 다기관 1만명 데이터", "presenter": "박상준 외 (순천향대 부천병원)", "topic": ["CGM", "Korean T2D"], "key_finding": "HbA1c -0.45%, TIR +9.2%, 중증 저혈당 -38%", "kor_relevance_score_note": "HIRA 급여 확대 정당성 학회 발표", "relevance": ["CGM"]},
  {"abstract_id": "ATTD-2026-O-187", "conference": "ATTD 2026", "session_date": "2026-02-23", "session_type": "Oral", "title": "Non-invasive wearable glucose trending devices: where are we (Apple, Movano, Rockley)?", "presenter": "Klonoff DC, et al.", "topic": ["WEARABLE", "non-invasive"], "key_finding": "All current devices fail ISO 15197; wellness-only labels only", "kor_relevance_score_note": "한국 wellness 등급 분류 정책 reference", "relevance": ["WEARABLE"]},
  {"abstract_id": "DTM-2026-O-31", "conference": "DTM 2026", "session_date": "2026-11-07", "session_type": "Oral", "title": "Cybersecurity for AID systems: post-market vulnerability disclosure trends 2024-2026", "presenter": "Klonoff DC, Kovatchev BP, et al.", "topic": ["AID", "cybersecurity"], "key_finding": "37 CVEs across AID ecosystem; SBOM mandate reduced response time 41%", "kor_relevance_score_note": "KFDA 사이버보안 가이드라인 정합", "relevance": ["AID", "CGM"]},
  {"abstract_id": "ATTD-2026-P-602", "conference": "ATTD 2026", "session_date": "2026-02-21", "session_type": "Poster", "title": "Eversense 365-day implantable CGM pivotal data: accuracy and patient experience", "presenter": "Garg SK, et al.", "topic": ["CGM", "implantable"], "key_finding": "MARD 8.5%, 92% would recommend; 1-yr wear feasibility confirmed", "kor_relevance_score_note": "한국 implantable CGM 도입 가능성 평가 자료", "relevance": ["CGM"]}
]